Efficacy and safety of long-acting risperidone injection after switching from antipsychotics in Chinese patients

被引：0
|
作者：
Li, H. F. [1 ]
Gu, N. F. [1 ]
Zhou, M. [2 ]
Jia, F. J. [3 ]
Zhao, Z. H. [4 ]
Fan, J. X. [5 ]
Wang, G. [6 ]
Sun, X. L. [7 ]
Li, M. [8 ]
Zhang, J. B. [9 ]
机构：
[1] Shanghai Mental Hlth Ctr, Shanghai, Peoples R China
[2] Beijing Univ, Mental Hlth Inst, Beijing, Peoples R China
[3] Guangdong Mental Hlth Inst, Guangdong, Peoples R China
[4] GuangZhou Brain Hosp, Guangdong, Peoples R China
[5] Nanjing Brain Hosp, Dept Psychiat, Nanjing, Peoples R China
[6] Beijing Anding Hosp, Beijing, Peoples R China
[7] Sichuan Huaxi Hosp, Dept Psychiat, Chengdu, Peoples R China
[8] SuZhou Guangji Hosp, Suzhou, Peoples R China
[9] Zhongshan Univ, Affiliated Hosp 3, Guangdong, Peoples R China
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2007年 / 17卷
关键词：
D O I：
10.1016/S0924-977X(07)70606-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S405 / S406
页数：2
相关论文
共 50 条
  • [31] Open study of efficacy and safety of long-acting risperidone (injection) in the adjuvant maintenance therapy for bipolar and schizoaffective patients
    Popova, E.
    Benabarre, A.
    Sanchez-Moreno, J.
    Leighton, C.
    Molina, O.
    Vieta, E.
    BIPOLAR DISORDERS, 2007, 9 : 86 - 86
  • [32] Pharmacokinetics and efficacy of a direct switch from conventional depot to risperidone long-acting injection in Chinese patients with schizophrenic and schizoaffective disorders
    Lai, Ying-Ching
    Huang, Ming-Chyi
    Chen, Chun-Hsin
    Tsai, Chang-Jer
    Pan, Chun-Hung
    Chiu, Chih-Chiang
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2009, 63 (04) : 440 - 448
  • [33] Efficacy and safety of long-acting risperidone: A direct switch from oral atypicals
    Schmauss, M
    Schreiner, A
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S397 - S398
  • [34] Study of the efficacy and safety of risperidone long acting injection in elderly schizophrenia patients
    Inoue, Y.
    Suzuki, H.
    Ootomo, M.
    Takeda, S.
    Kawaguchi, Y.
    Gen, K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S438 - S438
  • [35] Long-Acting Risperidone and Oral Antipsychotics in Schizophrenia Reply
    Rosenheck, Robert A.
    Krystal, John H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (23): : 2265 - 2266
  • [36] Clinical and functional outcomes of patients with schizophrenia treated with risperidone long-acting injection versus oral antipsychotics
    Olivares, J. M.
    Morales, A. Rodriguez
    Diels, J.
    Povey, M.
    Lam, A.
    Zhao, Z.
    EUROPEAN PSYCHIATRY, 2008, 23 : S126 - S127
  • [37] Long-Acting Risperidone and Oral Antipsychotics in Unstable Schizophrenia
    Rosenheck, Robert A.
    Krystal, John H.
    Lew, Robert
    Barnett, Paul G.
    Fiore, Louis
    Valley, Danielle
    Thwin, Soe Soe
    Vertrees, Julia E.
    Liang, Matthew H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (09): : 842 - 851
  • [38] Cost-consequences analysis of switching from oral antipsychotics to long-acting risperidone in the treatment of schizophrenia
    Esposti, L. Degli
    Sangiorgi, D.
    Ferrannini, L.
    Spandonaro, F.
    Di Turi, R.
    Cesari, G.
    Limonta, G.
    Buda, S.
    JOURNAL OF PSYCHOPATHOLOGY-GIORNALE DI PSICOPATOLOGIA, 2012, 18 (02): : 170 - 176
  • [39] Efficacy and safety of risperidone long-acting injectable in stable psychotic patients previously treated with oral risperidone
    Schmauss, Max
    Sacchetti, Emilio
    Kahn, Jean-Pierre
    Medori, Rossella
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (02) : 85 - 92
  • [40] Long-acting injectable risperidone - A direct transition from conventional antipsychotics
    Naber, D
    Schreiner, A
    EUROPEAN PSYCHIATRY, 2005, 20 : S76 - S77
12345